Updated on 27 January 2015
Gavi is a global vaccine alliance
Singapore: Vaccine manufacturers from around the world have pledged to come forward to support the immunization of 300 million children in the world's poorest countries between 2016 and 2020.
Gavi, a global vaccine alliance, hosted Gavi pledging conference on January 26, 2015 in Berlin to mobilise funds for global immunisation programmes through 2020.
"It is encouraging to see vaccine manufacturers increasingly recognizing the importance of sustainable vaccine markets for developing countries," said Dr Seth Berkley, CEO, Gavi. "The commitments made today will help us make more vaccine doses available at a lower cost and will support countries as they move towards financing and sustaining their own immunization programs. This will lead to more children being protected and more deaths being averted."
Various initiatives taken by vaccine manufacturers include:
Biological E - Is offering a five-year price commitment to Gavi graduated countries for its pentavalent vaccine.
GSK - Extended it price freeze commitment so that developing countries that graduate from Gavi support will be able to continue to purchase vaccines against pneumonia, diarrhoea and cervical cancer at significantly discounted Gavi prices for a decade after graduation. GSK also reaffirmed that if the company identifies new manufacturing efficiencies that reduce the costs of producing these vaccines, it will pass those savings on to Gavi and its donors.